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Abstract 
Background: To determine the role of chorionic 
villi examination in the prenatal diagnosis of ß- 
thalassaemia  
Methods: In this descriptive study  couples 
requesting  prenatal diagnosis (PND) for  ß- 
thalassaemia were registered for chorionic villous 
sampling after 10 weeks of gestation.  After 
appropriate counseling placental sample was taken 
under local analgesics with suction cannula by trans-
abdominal approach.  The sampling system was then 
withdrawn  under  negative pressure .Placental villi 
were  proceeded for further DNA analysis.  Each 
PND was carried out by including the parents DNA, 
fetal DNA for the mutation, as well as the normal 
gene, appropriate negative and positive controls and 
reagent blanks.  
Results: Six hundred and twenty females 
underwent chorionic villi sampling. Most patients 
(82.25%) , who requested for PND, already had an 
affected child. Consanguineous marriages were 
present in 83.20% ..The average reporting time for 
identification of the  mutation was  7 to 10 days. 
Thalassaemia major was found in 25.48%. In the case 
of ß- thalassaemia major,  majority (98.73) opted for 
termination of pregnancy. Spontaneous abortion, 
after the procedure was found in one case .Two cases 
turned out false negative.  The commonest mutations 
were Fr8-9 (40.85% ) and IVS 1-5(25.70%) .  
  Conclusion: Pre natal diagnosis for ß- 
thalassaemia by  chorionic villi examination is a safe 
and cost effective procedure.  
Key Words: Prenatal diagnosis, Chorionic Villi, ß- 
thalassaemia 
Introduction 
ß- thalassaemia is the commonest single gene disorder 
in Pakistan. Approximately 5% of the population 
carries ß- thalassaemia trait and each year over 6000 
new children are  born with ß- thalassaemia major .1  
The cost of treatment of thalassaemia is often beyond 
the reach of a person with an average income . The 
best possible solution  is the prevention of birth an 
affected child. 2 Married couples, where both partners 
are carriers need to be offered  prenatal diagnosis 
(PND). The response of couples to PND  is 
encouraging.  3 
Chorionic villous sample (CVS) is an effective mean of 
prenatal diagnosis. Ultrasound guided trans-
abdominal sampling is the procedure of choice for 
chorionic villous sampling . The main advantage of 
trans-abdominal technique  is its utilization from first 
trimester to term. For PND , CVS in first trimester is 
advantageous, as being of less emotional and physical 
stress and  less obvious pregnancy. If termination is 
indicated, the contemplation of procedure will be safer 
in first trimester . Religious scholars, with medical 
professionals on board, allow it in first trimester.4 
When compared to the accumulated cost of long term 
treatment of ß-thalassaemia, cost  incurred in chorionic 
 villous sampling and laboratory diagnosing  ß- 
thalassaemia mutations is negligible. 4Better control of 
major communicable diseases is leading to  a decline 
in infant morality . As a consequence  inherited  
disorders are becoming a recognized problem. At 
present the health facilities in developing countries are 
inadequate to face the challenge of inherited disorders, 
like thalassaemia . The  best approach, to deal these 
disorders, is preventive programmes including carrier 
screening and prenatal diagnosis. 5 
The spectrum of mutations in all ethnic groups, 
studied in Pakistan, is heterogeneous. This 
heterogeneity appears to be due to geographic location 
of Pakistan , particularly Northern Pakistan, which has 
been the gate way for most invasions of Indian 
subcontinent. Genetic studies utilizing molecular 
analysis are detrimental, as these can delineate the 
genetic status. In case of a fetus under analysis it  helps 
in suggesting different options to the parents, after 
giving due credence to the fetus fate ,i.e., homozygous, 
heterozygous or normal. Family can be counselled in 
accordance with it . 5   
Patients and Methods 
The couples requesting PND for  ß- thalassaemia were 
registered for chorionic villous sampling after 10 
weeks of gestation. Couples were counselled about the 
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diagnostic procedure, possible outcomes of the test 
and the chances of misdiagnosis . After appropriate 
counselling of the couples, placental sample was taken 
under local analgesics with suction cannula by trans-
abdominal approach. Every patient was placed in 
supine position and placenta was localized by trans-
abdominal ultrasonography.  Needle was  inserted 
using free hand technique under ultrasound guidance. 
Needle was advanced at an angle that allowed it to 
penetrate along the long axis of placenta . Stillet was 
then removed. Fifty c.c  disposable syringe was 
mounted on holder and the holder was attached to the 
hub of the needle  (Figure 1).The needle tip was 
removed back and forth inside the placenta applying a 
continuous  suction  until an adequate sample had 
been aspirated (5-10 mg of chorionic villous was 
needed). The sampling system was then withdrawn  
under  negative pressure .Chorionic villous sample 
was dissected under a stereo-microscope . Maternal 
tissue , if any, was carefully separated and placental 
villi were  proceeded for further DNA analysis. The 
parents’ blood samples and CVS were tested for  ß- 
thalassaemia  mutations , found in Pakistani 
population by a Multiplex Amplification Refractory 
Mutation System (ARMS). Each PND was carried out 
by including the parents DNA, fetal DNA for the 
mutation, as well as the normal gene, appropriate 
negative and positive controls and reagent blanks.  
 
Figure1: Ultrasound guided collection of chorionic villous 
sample  
Results 
Most patients (82.25%) , who requested for PND, 
already had an affected child. Consanguineous 
marriages were present in 83.20% (Table 1). The 
average reporting time for identification of the  
mutation was  7 to 10 days. Thalassaemia major was 
found in 25.48% (Table 2). The commonest mutations 
were Fr8-9 (40.85% ) and IVS 1-5(25.70%) ( Table 3; 
Figure 2)  
Discussion 
Gradually the prenatal diagnosis of beta thalassaemia 
is getting acceptance , after favourable response by 
religious scholars . 6,7  In a society like Pakistan , where 
It is not possible for the majority to afford the cost of   
Table 1: Prenatal diagnosis – Demographic 
profile 
Characteristic No(%) 
Primigravida 
2nd pregnancy 
 3rd pregnancy 
14 (3.87) 
94(15.16) 
502(80.97) 
Already having an affected child 510(82.25) 
Mean maternal age(years) 
Mean(Range) 
28.0 (18-39) 
Mean gestational age (weeks) 13.0 
Consanguineous marriages 516(83.2) 
1st cousin 466(75.16) 
Table 2: Prenatal diagnosis -  CVS results  (n=620) 
Parameter No(%) 
Thalassaemia major 158(25.48) 
Thalassaemia minor 282 (45.48) 
No thalassaemia mutation found 176(28.38) 
Inconclusive 4(0.64) 
Termination of pregnancy 156/158 (98.73) 
 Loss of pregnancy 1/620 (0.16) 
Refused abortion 2/158 (1.26) 
Error rate 2/458(0.43%) 
Table 3:CVS sampling-Molecular diagnosis in 
fetuses with ß- thalassaemia major  (n=158) 
Mutation No(%) 
Fr 8-9 (+G) 64(40.85) 
IVS1-5 (G-C) 41(25.70) 
Fr 41-42 (TTCT) 11(6.96) 
Cd 15(G - ) 06(3.79) 
Del619 07(4.43) 
Cd 30 (G-C) 06(3.79) 
Cd5 (-CT) 06(3.79) 
IVS1-1 06(3.79) 
Others 11(6.96) 
 
 
Figure 2: Mutation(1-5):1.  Father (Fr 8-9) ;2.  Mother (Fr 8-
9) ;3.  CVS (Fr 8-9) ;4.  CVS (Fr 8-9) ;5.  -ve ;Normal Gene (6-
10): 6.  CVS;7.  CVS;8.  +ve ;9.  -ve ;10. Blank 
 
prenatal diagnosis, it is an encouraging respite from 
Punjab Thalassaemia Prevention Programme (PTPP) to 
provide free PND services (Collection of chorionic 
villous sample  and mutation analysis). PTPP is 
catering whole of the province through its field 
officers. In Rawalpindi it is catering districts of 
Rawalpindi, Mianwali, Jhelum, Gujrat, Chakwal, 
Khoshab, Sargodha and  Attock. People from Khyber 
Pukhtonkhwa , Gilgit Baltistan and Azad Jammu and 
Journal of Rawalpindi Medical College (JRMC); 2017;21(2): 109-112 
 111 
Kashmir are also taking benefit of this facility. The 
provision of CVS sampling in first trimester of 
pregnancy has a  better acceptability. Studies revealed 
that majority of chorionic villi  sampling are usually 
employed in first trimester. 3,4,8-10  In case of 
homozygous fetus the interruption of pregnancy 
would be physically and emotionally more acceptable 
in early gestation. 11 The estimated birth rate of babies 
born with ß thalassaemia   major in Pakistan is around 
6000 per year. This means  a requirement  of  
approximately 20,000 PND each year . With only a few 
centres providing PND services the catering number is 
far away from satisfaction.3  
Lack of awareness is an important impediment , but 
mothers’ education lead to a significant improvement. 
12 It is required to have a prospective identification of 
couples at risk. 13 Majority of the couples utilizing 
PND services already have an affected child. To check 
this trend prospective identification of at risk couples 
and families is a plausible solution . The extended 
family screening in cohorts where there is already a 
case of beta thalassaemia  , is the most feasible 
preventive programme . 14 The Punjab Thalassaemia 
Prevention Programme is going in the right direction 
by approaching extended families for thalassaemia 
screening in all districts of Punjab through field 
officers and by providing facility of hemoglobin 
electrophoresis, free of cost.  
In majority of cases diagnosis  is positive by mutation 
analysis, but in a few linkage  analysis is required. 3 
Uptil now more than 200 mutations have been  
reported in ß globin chain synthesis . Out of these 25% 
have been found in heterogeneous subcontinent Indo-
Pak population. In a carrier couple, with an autosomal 
recessive inheritance , there is 25% risk of having a 
fetus with ß thalassaemia major, 25% chance of normal 
conception and 50% chance of a fetus with ß 
thalassaemia   minor . Prenatal diagnosis can delineate 
this status , thereby, helping in reducing the disease 
burden. 15. Results of present study, for mutation 
analysis, are in agreement with other studies in 
Pakistan which show predilection of Fr8-9 and IVS1-5 
mutations .16-18   Fr 8-9 (+G) is the most common 
mutation in Northern Pakistan, whereas IVS1-5 (G-C) 
is the most frequent mutation in Southern Pakistan . 5  
Mediterranean region studies revealed IVS 1-1 (G-A) 
IVS1-110(G-A), IVS1-6 (T-C) as predominant  beta 
thalassaemia mutations. 19 PND is technically  feasible 
in Pakistan by direct mutation analysis in 97%  of cases 
and then in remaining by linkage analysis. Technique 
has an acceptable error rate . Proportion of cases 
diagnosed as ß thalassaemia major (25.48 %), in 
present study, is equal to the expected 25%. To 
maintain the reliability of PND services a strict 
protocol of DNA analysis with rigorous standards of 
quality  is required. 3,20  In a study by Old et al , in a 
sample group of  3254 pregnancies, diagnostic issues 
were recorded, arising from non-laboratory errors 
(0.31%) and fifteen 15 due to technical problems 
associated with the diagnostic techniques. The latter 
group consisted of eight misdiagnoses by globin chain 
synthesis (1.55%), five by Southern blot analysis 
(0.73%) and two by PCR methods (0. 10%). Accuracy 
of prenatal diagnosis has improved with each 
development of diagnostic technique, and confirms 
that prenatal diagnosis of beta-thalassaemia and sickle 
cell disorders by ARMS-PCR is very accurate and 
reliable. The overall error rate for prenatal diagnosis 
by PCR methods in the UK is now 0. 41%. 8  In the 
present study the error rate is 0.43%, higher than 0.1% 
by Old et al (2000).  8 It can be ascribed to technical 
problem or  maternal contamination in the CVS. The 
error rate can be reduced by taking additional steps 
like duplicate testing or linkage analysis, but this 
would increase the cost of testing. 3  Chorionic villous 
sampling  with mutation analysis revealed sensitivity 
and specificity of 98.7% and 100%,  respectively. 
Results of present study are comparable to 
Ghahramani  F et al (2014).21  Ayub R et al had a 
sensitivity of 75% and specificity of 91%.22 Factors 
leading to misdiagnosis  are clerical mistakes and 
maternal contamination of chorionic villous sampling.6 
Consanguineous marriages, common in Pakistan, have 
compounded the problem. In present study 
consanguinity was observed in 84.48% couples.  A 
study from Karachi revealed consanguinity in 59%. It 
can be ascribed to more urban and literate society in 
Karachi. 23,24Screening practices are in vogue , yet in 
our set up most of the couples , having a child with  ß 
thalassaemia major, give history of screening after the 
birth of  an affected child. Factors identified for the 
under utilization of CVS sampling , in our set up , 
include lack of awareness, poor access, delay in 
seeking advice, non-affordability and religious bias . 
12,25-28  Many refuse to utilize the procedure due to 
inadequate or illogical explanation of the procedure . 
But if properly counseled then majority opted for  the 
procedure and choose to terminate the pregnancy if 
fetus is suffering from ß thalassaemia major . 
Complications associated with the procedure and fetal 
loss is minimal  .This needs to be properly imparted as 
many refuse to utilize the procedure due to inadequate 
explanation of the procedure . 
A family with a child of ß thalassaemia major, 
approximately has to spend 20 to 30% of its earning as 
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the running treatment expenses of that child. For an 
ideal treatment these expenses can go beyond this. But 
the cost incurred on CVS and laboratory diagnosis of 
beta thalassaemia mutations is negligible. 4,5,14,25     
In present study there was one case of fetal  loss. Post 
CVS fetal loss is reported  from 1.3 to 3.0% 11,29-32 
Procedure related complications in 2.4% cases and 3% 
couples refused to abort a homozygous fetus. 11 
Chorionic villous sampling  is an invasive procedure. 
Non invasive approaches like enrichment of fetal zeta 
globin containing nucleated red blood cells from 
maternal blood, are giving positive results. 33-35  
Conclusion 
1. PND for ß- thalassaemia, by  chorionic villi 
examination, is a safe and cost effective procedure  
2. There is a need to increase utilization of prenatal 
diagnosis for thalassaemia prevention 
3. Strict quality assurance can  ensure an acceptably 
low error rate  
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